The CDD team are validating several rapid tests to detect SARS-COV-2 antibodies in a finger prick or venous blood sample.
These simple to use tests produce results in 10-15 minutes and can be run from home as well as at the point-of-care. Evaluations are being conducted both within LSTM and on behalf of the Foundation of Innovative New Diagnostics, a not-for-profit specialising in infectious disease diagnostics. LSTM is the only site selected from the UK. Samples collected through the FASTER and with LCL (Liverpool Clinical Laboratories), and a panel of pre-pandemic COVID-19 negative samples are being used to assess test sensitivity and specificity.